As Thailand gradually moves toward a post-pandemic position, the National Communicable Illness Committee of Thailand decided to downgrade COVID-19’s designation from “dangerous infectious disease,” which took effect on March 1, 2020, to “infectious disease under watch,” tentatively starting on October 1. Covid is no longer regarded as a “serious infectious disease” by Thailand’s Communicable Disease Committee. Anutin stated that the committee will permit state hospitals to purchase anti-viral drugs independently rather than waiting for deliveries from the Government Pharmaceutical Organization and to claim refunds later, like other infectious diseases, in order that the public will have better access to medication. This will allow post-pandemic management to remain in line with the changing situation. The committee has also given the go-ahead for hospitals to administer patients Long-Acting Antibody (LAAB). Covid is no longer regarded as a “serious infectious disease” by Thailand’s Communicable Disease Committee.
The committee is aware that more people are becoming infected, but they are also well-informed on COVID-19 and the value of infection prevention measures. The committee, which was presided over by Public Health Minister Anutin Charnvirakul, also approved a policy guideline framework that covered several aspects of COVID-19 monitoring and containment efforts. These included limiting the spread of the disease by considering the number of patients hospitalized, bed occupancy by severe cases, access to vaccines and anti-viral medications, adjusting quarantine measures, public awareness campaigns to encourage vaccination, and a variety of other factors.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments